Skip to content

GENEWIZ Week Workshops

We invite you to take a dive into AI-powered antibody development, explore multimodal single-cell and epigenomic insights into Alzheimer’s disease and/or revisit the game-changing scientific breakthroughs of the 1990s and how they’ve shaped the research landscape today.

Whether you’re here for the data, the deep learning, or just to relive the golden age of gene therapy and grunge, you’ll leave with fresh perspectives and tools to level up your science. So grab your slap bracelets, load up your floppy disks, and get ready to say “Talk to the data!” because this year’s GENEWIZ Week is all that and a bag of pipette tips.

 

Untitled design - 2025-07-25T163413.676

Andrea O'Hara, Ph.D.

Senior Product Manager, GENEWIZ from Azenta Life Sciences

PREMIERES TUESDAY, SEPTEMBER 9, 2025 | 11:00 AM EST

Now That’s What I Call Genomics:

Biotech Advancements from the ‘90s and How They Impact Us Today 

Rewind the VHS and revisit key highlights in science from the 90’s, including the Human Genome Project, cloning of Dolly the Sheep, the first successful gene therapy and how these impact our current research today. 

Untitled design - 2025-07-25T163424.046

Ammar Arsiwala, Ph.D. 

Director, Antibody Development Gingko Bioworks, Inc

PREMIERES WEDNESDAY, SEPTEMBER 10, 2025 | 11:00 AM EST

The Clone-Files:

Data-Driven Antibody Engineering with the PROPHET-Ab Platform 

Discover how the PROPHET-Ab platform gets jiggy with data-driven insights on developability properties to guide antibody development and accelerate therapeutic development with AI/ML modelling.

Untitled design - 2025-07-25T163438.308

Feixiong Cheng, Ph.D. 

Director, Genome Center Cleveland Clinic

PREMIERES THURSDAY, SEPTEMBER 11, 2025 | 11:00 AM EST

Saved by the Single Cell:

A Scalable Human Brain Cell Atlas Foundation Model in Alzheimer’s Disease 

Explore fresh findings using multimodal single-cell/nucleus genomics/epigenomics analytic approaches, along with interpretable deep learning and in silico network medicine, to uncover molecular networks between disease-associated microglia and astrocytes with implications for Alzheimer’s disease drug repurposing.